Pharma IQ Members

107 results
of 11
November 21, 2017 by Joyce El Hokayem
default profile icon
Human Genetics Scientist, Joyce El Hokayem examines the benefits phytomedicine could offer to today’s healthcare systems and the challenges researchers in this market face
Tags:
October 30, 2017 by Regina Au
Regina Au
While social media is taking the consumer world by storm, the medical industry has been a bit shy to fully embrace these channels because of regulatory requirements.
Tags:
September 26, 2017 by Dr Steven Bradshaw
Dr Steven Bradshaw
Pharma treads a fine line to the tipping point where there is insufficient time to recoup a drug’s costs, due to the number of years left that the patent can run.
Tags:
September 5, 2017 by Pharma IQ
Pharma IQ
As pharma spend continues to climb, so does public scrutiny on drug pricing. Once again, medicine manufacturers are spurred to strike a fair solution to balance raging its R&D appetites with affordable access to treatments for patients
Tags: pharma, medicine, drug, price, prices, spending, disease, treatment, cure, spend, R&D, manufacturers, Big pharma, biotech, small pharma
August 29, 2017 by Dane Hartung
Dane TN
Dane Hartung, Director Marketing and Access, Fougera Pharmaceuticals shares best practices for determining if and when you should implement a new Commercial Patient Access Program. Dane also discusses how you should go about ensuring your patient access program is ethical, compliant and effectively differentiates your product.
Tags:
July 11, 2017 by Pharma IQ
Pharma IQ
Despite some in the market choosing to shut down certain departments, many in the pharma industry are embarking on expansions. Ireland is expected to see a lot of growth
Tags: pharma | medicines | cure | treatment | drug | drug development | research and development | Novo Nordisk | Almac | msd ireland | Shire | Eli Lilly | DHL | Mallinckrodt | J&J | Takeda Pharmaceuticals | Biopharma Engineering
June 20, 2017 by Pharma IQ News
Pharma IQ News
The Reputation Institute has revealed the top 10 most reputable pharma companies as voted by the general public. In a surprising result, AstraZeneca and GSK both failed to make the top 10.
Tags:
June 13, 2017 by Chanice Henry
Chan
Astrazeneca and its biologics arm, Medimmune, advance in the R&D race as three new oncology drug candidates see promising developments
Tags:
May 9, 2017 by Pharma IQ
Pharma IQ
Pharma IQ explores the power behind medicine optimisation and the trends emerging in the pharma and healthcare market recently.
Tags:
April 18, 2017 by Ash Rishi
Ash Rishi
Patient education is an important factor in disease self-management, and when handled properly it has been found to have a significant, positive impact on improving patient outcomes.
Tags: Pharmaceutical, medicines, cure, treatment, drug, medicine, disease, condition, illness, sickness, patient, pharma, bio pharma, drug development, healthcare,
107 results
of 11